The latest business, scientific & regulatory news from the pharmaceutical and biotechnology industries. Trends & international news from global correspondents and breakthroughs in research in Coming Down the Pike.
November 20, 2009 By:Stephanie Sutton Pharmaceutical Technology Europe
Engineers at a UK university claim to have developed technology that can be used in existing chemical reactors to ensure right first time drug crystal formation, which is crucial to their efficacy and the efficiency of pharmaceutical manufacturers' operations.
 |
November 19, 2009 By:Fedra Pavlou ePT--the Electronic Newsletter of Pharmaceutical Technology
Around half of all multiple sclerosis (MS) patients that are eligible for treatment do not receive it and one in five of those patients that do begin therapy, delay doing so because of fear and anxiety over the treatment process, and not fear and anxiety about the disease.
 |
November 19, 2009 By:Erik Greb ePT--the Electronic Newsletter of Pharmaceutical Technology
Last week, GlaxoSmithKline (GSK, London) agreed to donate 50 million doses of its adjuvanted pandemic influenza A (H1N1) vaccine to the World Health Organization (WHO).
 |
November 19, 2009 By:Angie Drakulich ePT--the Electronic Newsletter of Pharmaceutical Technology
The international pharmaceutical supply-chain consortium Rx-360 held a launch meeting in Europe last week with more than 135 industry and regulatory representatives in attendance.
 |
November 19, 2009 By:Patricia Van Arnum ePT--the Electronic Newsletter of Pharmaceutical Technology
Following the its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) Pfizer detailed plans for its global research and development (R&D) network, which includes consolidation of its R&D facilities.
 |
November 12, 2009 By:Patricia Van Arnum ePT--the Electronic Newsletter of Pharmaceutical Technology
Novartis reported that German regulatory authorities approved its adjuvanted cell culture-based Influenza A (H1N1) 2009 monovalent vaccine, Celtura. The company also said it will acquire a stake in Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical.
 |
November 12, 2009 By:Patricia Van Arnum ePT--the Electronic Newsletter of Pharmaceutical Technology
The European Medicines Agency, the European Center for Disease Prevention and Control, and the Heads of Medicines Agencies issued a European strategy for H1N1 vaccine benefit–risk monitoring.
 |
November 12, 2009 By:Erik Greb ePT--the Electronic Newsletter of Pharmaceutical Technology
On Sunday, Nov. 8, 2009, the Pharmaceutical Research and Manufacturers of America (PhRMA) expressed its disappointment with the US House of Representatives's healthcare-reform bill.
 |
November 12, 2009 ePT--the Electronic Newsletter of Pharmaceutical Technology
The American Association of Pharmaceutical Scientists (AAPS) recognized researchers at the organization's 2009 Annual Meeting and Exposition in Los Angeles this week.
 |
|